Clinical research
Kaiser Permanente’s innovative, translational research is essential to providing members with high-quality, evidence-based care that improves outcomes. Discover how clinical research drives medical advancements and shapes the care found at Permanente Medical Groups.
Active tuberculosis linked to higher long-term risk of death
September 29, 2020
A Kaiser Permanente study found that increasing tuberculosis screening and prevention efforts could potentially help improve life expectancy.
Teens, parents, physicians support screening young people for gender identity, study suggests
September 17, 2020
A new study led by Permanente physician-researchers found young people felt more comfortable talking about gender identity issues when asked first by a clinician.
New virtual, innovative clinical trial for adults at high risk for respiratory illnesses
August 25, 2020
Kaiser Permanente researchers to study Vascepa in people 50 and older with heart disease.
Kaiser Permanente joins phase 3 clinical trial for COVID-19 vaccine
August 13, 2020
The late-stage clinical trial will test the vaccine in 1,400 adults at 4 sites in California and Oregon.
Living longer and better after cancer
June 12, 2020
Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life.